VBI Vaccines to continue enrolment for Phase I trial of CMV vaccine candidate

VBI Vaccines has been recommended to continue enrolling patients for its Phase I clinical study in order to evaluate its preventative cytomegalovirus (CMV) vaccine candidate.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news